80
Participants
Start Date
March 31, 2002
Visilizumab
The New York Hospital Cornell Medical Center, New York
Westchester Medical Center, Valhalla
Duke University, Durham
H. Lee Moffitt Cancer Center & Research Institute, Tampa
Ohio State University, Columbus
Cleveland Clinic Foundation, Cleveland
University Hospital, Indianapolis
Washington University School of Medicine, St Louis
Baylor University Medical Center, Dallas
Baylor College of Medicine, Houston
MD Anderson Cancer Center, Houston
City of Hope National Medical Center, Duarte
Fred Hutchinson Cancer Research Center, Seattle
Stanford University Medical Center, Stanford
Dana Farber Cancer Institute, Boston
University of Massachusetts Medical School, Worcester
Vanderbilt University Medical Center, Nashville
Collaborators (1)
Facet Biotech
INDUSTRY
Fred Hutchinson Cancer Center
OTHER